Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells - Wikidata - awgldk - TriplyDB

Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells

Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells

http://www.wikidata.org/entity/Q34749359

about

Roles of IL-33 in Resistance and Tolerance to Systemic Candida albicans Infections The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Serum IL-33 level is a predictor of progression-free survival after chemotherapy.Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer.Interleukin-1 is required for cancer eradication mediated by tumor-specific Th1 cells.Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages Tumor-infiltrating macrophages express interleukin-25 and predict a favorable prognosis in patients with gastric cancer after radical resection Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment.Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.Intratumorally Establishing Type 2 Innate Lymphoid Cells Blocks Tumor Growth.Alarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses Tumor-associated macrophages in cancers.IL-33 acts as a foe to MIA PaCa-2 pancreatic cancer.Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy.IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer.Interleukin-33 in health and disease.IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils.IL33 Promotes Colon Cancer Cell Stemness via JNK Activation and Macrophage Recruitment.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice.IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.IL‑33 enhances glioma cell migration and invasion by upregulation of MMP2 and MMP9 via the ST2-NF-κB pathway.Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.Alarmins and immunity.Interleukin-33 Expression does not Correlate with Survival of Gastric Cancer Patients.Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer.Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.Integrated Expression Profiles Analysis Reveals Correlations Between the IL-33/ST2 Axis and CD8+ T Cells, Regulatory T Cells, and Myeloid-Derived Suppressor Cells in Soft Tissue Sarcoma.Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine The Role of IL-33/ST2 Pathway in Tumorigenesis IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE

P2860

Q26747318-8AB3AF4B-6829-4EF3-A13A-AC7167AC56C6 Q33593742-B58CE1C0-4638-4DBD-9337-890BB0D2FDC9 Q33798754-6205C67C-6B24-4837-93EF-4C77D1F72B7C Q35754479-8A1EDA0C-B52E-4C1E-8FC3-8CF9A59471F0 Q36440299-E1EA3665-6F73-462E-B1B5-F01F7D95A17C Q36473012-E2414BCE-B069-4FEC-8BA4-F82DA0D3EC47 Q36597474-739A0A56-D57E-4399-960D-D8D78CD2E0E7 Q36597506-5D7A9946-38C2-4449-87F6-13EBBFE8BF82 Q36876563-2F8E0A8B-E39A-445E-9B89-89EB1D166E06 Q36998164-5C1409C5-B67E-4CA9-A53E-E8DE6B20A8A5 Q37439634-FE7A0C05-76B1-4DA5-8C92-BBBD48D1CBE6 Q37571181-772F2CC0-E43C-48F6-BA8B-7EA8F179C503 Q37641560-59329F61-ED8F-4E13-897D-3AA3A1801CCF Q38417709-B8DD890D-63BF-4BF3-8B69-CC06A32A8D46 Q38530106-8883E0A2-4708-4DFD-800E-F8CE745DE76D Q38564735-B402274B-4087-4D14-A0E4-4D38E9938AFA Q38722744-D9AE720C-7C05-4E5B-91A0-5BC8B3E04A79 Q38753216-CCEC8463-0665-4D66-A049-7836339E9D8C Q38775054-AC01FFB0-12E1-4DE0-90AB-9FB1E15371C5 Q38783993-9100F64D-EBAE-40E4-B46F-AD606BEAA9F5 Q38957840-B6474A62-A565-4B0F-9132-4D190DB90364 Q40146282-3460F42C-F253-4CD4-BFBA-FDD959C8356D Q40312760-0321FA22-1CB4-4D3B-B71E-91E1ED63A92A Q40470696-D0C480F2-FB26-47B7-9086-992A4EB38444 Q40924863-CE9AA9C3-1FD5-4EA8-A9A8-237D140F8671 Q41019883-7581F08F-B619-47D8-A00F-EF84B6922328 Q41972983-5B840668-C4BF-43B5-84A9-5DFA6FF6EF03 Q46504021-5D0C18CA-A08A-4843-B939-BD694B7D5F32 Q46866026-9F411405-5CDD-430D-B018-4753386CDF4F Q48120429-80A35B36-7327-427A-ADC0-D1A76262FE3B Q48193695-7BE314E7-27A8-4255-9A3E-F3FE3F7A299F Q51070624-14E1F0B1-8165-4E70-A0B7-5CE64D6E35D7 Q52641579-8841503A-D4FE-4E52-B25B-BA26F6C87BDB Q52853207-BFFB831E-712F-4659-A127-DC905BD8C9EA Q55208795-FE3C153A-C17C-4624-B88A-4F30D8151F6B Q55275991-25525874-7CB2-4A91-963B-7B2D8DF822A0 Q55373264-4C716C50-3FD6-4610-ABE1-7DE24039AA62 Q58707724-520B1AA0-8F1F-4FCC-A48F-EC6BEF218E5A Q58756972-D41F56E3-7D02-4221-AA01-86D0232EF3D5 Q58770481-2D442073-DF5D-4073-8A8E-2DD1764DF597

P2860

Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells

http://www.wikidata.org/entity/Q34749359

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@ast

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@en

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@nl

type

label

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@ast

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@en

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@nl

prefLabel

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@ast

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@en

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@nl

P1433

Q34749359-A89DFB14-591C-410C-AB05-D5D976840375

P1476

Q34749359-AE3F7CC5-5F26-4214-9A91-BDB778CCC749

P2093

Q34749359-02538A25-6665-4C04-BE6F-F60F4C57A86A

Q34749359-0477193E-6F43-450F-A013-56AF007D6CA0

Q34749359-20D55473-87B8-4DAE-9710-45016B0E925A

Q34749359-49C8E772-2B8D-4282-8E6B-13A5E2350085

Q34749359-557376A5-A77C-4B2B-8172-16085FF694C6

Q34749359-57F0C768-E132-43F0-B990-C5E2EDFE203B

Q34749359-72B13B94-2A38-42B6-B843-C76CEBA95CD5

Q34749359-7DE475C2-DEC9-4708-9374-A8CD16F7302C

Q34749359-7FF24240-1699-4F2C-96DF-9374BBAB7FFD

Q34749359-A83789F5-FDE4-4804-8C52-D982BF0538AA

P2860

Q34749359-089A5F2F-83C2-4381-89FC-1FA642CEBC94

Q34749359-18A294EA-AF5C-48BA-BF32-7258163A9A7D

Q34749359-216A2D4E-D63F-41FD-BA7C-6676229B54E5

Q34749359-2CFF246B-2545-4665-9B5C-89E3DD898741

Q34749359-2E697419-8ED2-4082-95F3-571F8FEECDCB

Q34749359-31B82297-704F-417F-9080-E6854D3096AB

Q34749359-378B6F89-7CFD-48E6-ACC3-84EA70431E4B

Q34749359-3CF4D4C9-0229-4D85-9074-8BB5CA8A91BE

Q34749359-4188607F-A7DA-45D9-8CD3-B04AFA89E4DB

Q34749359-48B58FA0-04B2-4DE8-8BB1-073BE2C9FF48

P304

Q34749359-F5F7B6BA-4BBE-4533-96B9-F8547368A258

P31

Q34749359-BDFC67AB-62DC-4E22-A3AE-2062E61A2316

P356

Q34749359-94D89C12-430B-42B5-B07A-77D2C205E1A5

P407

Q34749359-53087419-8B3E-41DD-816D-C6172D6AF142

P433

Q34749359-85F36592-71A7-4944-AD3D-EF5EE774CA92

P478

Q34749359-15EC0D8C-E6FD-4897-BF33-68B14A301245

P50

Q34749359-1A6B520A-8D53-44ED-9542-F67B2489F898

P577

Q34749359-AA022ACD-D475-43CA-B41D-27E8E8CC381A

P5875

Q34749359-4EDFAFF9-06B8-48C8-A810-0DC4B04A3F5B

P698

Q34749359-0A2A49C6-DADB-46A0-82F5-C956BD37BF62

P932

Q34749359-07FBCF8B-0296-4FDB-B19C-10769718A4E9

P356

JIMMUNOL.1401344

P1433

Journal of Immunology

P1476

Tumoral expression of IL-33 in ...... nt through CD8+ T and NK cells

@en

P2093

Binfeng Lu

http://www.w3.org/2001/XMLSchema#string

Changping Wu

http://www.w3.org/2001/XMLSchema#string

Fang Xie

http://www.w3.org/2001/XMLSchema#string

Gang Li

http://www.w3.org/2001/XMLSchema#string

Jingting Jiang

http://www.w3.org/2001/XMLSchema#string

Junfeng Lu

http://www.w3.org/2001/XMLSchema#string

Qianting Yang

http://www.w3.org/2001/XMLSchema#string

Wen Wen

http://www.w3.org/2001/XMLSchema#string

Wenxin Qin

http://www.w3.org/2001/XMLSchema#string

Xin Gao

http://www.w3.org/2001/XMLSchema#string

P2860

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Nivolumab plus ipilimumab in advanced melanoma.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Myeloid-derived suppressor cells as regulators of the immune system

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Cancer immunoediting: from immunosurveillance to tumor escape

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

P304

438-445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1401344

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268984015

http://www.w3.org/2001/XMLSchema#string

P698

25429071

http://www.w3.org/2001/XMLSchema#string

P932

4272901

http://www.w3.org/2001/XMLSchema#string